Additional Funding Opportunity Through the SRI and Bayer Discovery/Innovation Grants

The Society for Reproductive Investigation (SRI) and Bayer are pleased to offer an additional grant to K Awardees who are currently funded. One $20,000 grant will be made available to the successful applicant. The application deadline for submission for consideration of an award is May 15, 2022.

The objective of the grant funding is to support the development of scientists and clinicians in the field of women's health. Funding is specifically provided to support and enhance the current research endeavors of these individuals. These awards are made possible by a generous grant from Bayer.

GRANTS MUST BE FOCUSED FOR THE FOLLOWING INDICATIONS:

• Polycystic Ovarian Syndrome (PCOS) and,
• Subfertility associated with PCOS,
• Endometriosis-associated subfertility (including adenomyosis uteri/endometriosis internal),
• Non-hormonal contraception,
• Uterine Fibroids (uterine leiomyoma)

APPLICATION REQUIREMENTS AND INSTRUCTIONS:

• Open to SRI Members
• Must be a currently funded K Awardee (K08, K12 {RSDP, WRHR, BIRCHW}, K23, K99/R00)
• Submit a two-page request including the aims of your current project and a one to two paragraph summary describing how the additional funding will be used to further enhance your current project
• Provide a budget explaining how the funds will be utilized

For more information or to submit your materials, please contact the SRI Office at info@sri-online.org or 414-918-9888.

Please read the instructions very carefully. Please note that the deadline cannot be extended for any reason.

TIMELINE:

April 7: Announce Grants
May 15: Grant Application Deadline
May 30: Letters to applicants distributed